Latest Breaking News On - Spine regulatory affairs - Page 1 : comparemela.com

Share this article Share this article WASHINGTON, May 12, 2021 /PRNewswire/  MCRA, LLC, the leading privately held medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Medical Device Cybersecurity, is pleased to announce its role in the successful management and execution of Simplify Medical s two clinical studies and approvals by the U.S. Food and Drug Administration (FDA) for the Simplify Cervical Artificial Disc (Simplify Disc) to be used at one-level and two contiguous levels in the cervical spine. Abigail Allen, MCRA s Vice President of Clinical Affairs, said, MCRA is honored to have supported Simplify Medical with the approval of their two-level disc just six months after the one-level approval. It has been a true testament to the teamwork and collaboration between the two companies, and all of our sites, to get the

District of columbiaUnited statesNew yorkElizabeth baldacchinoJustin eggletonAbigail allenKyle maloneClinical affairsDrug administrationViscogliosi brothersInternational regulatorySpine regulatory affairsRegulatory affairs at nuvasive incClinical research organizationClinical researchBusiness development